The patients in the treatment group were given arterial infusion of p53 gene ( Gendicine , Shenzhen Sibiono GeneTech Co , Ltd ) with Gendicine ( 10vp ) combined with hydroxycamptothecin ( 20 mg ) , once a week , for a course continuously for 3 weeks .